[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
MoonLake Immunotherapeutics Class A Ordinary Shares
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -XX%
6 Months: XX% +34%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-01-26
1-Year Low: XX% on 2024-12-25
Most Supportive Themes
- Potential for a Buyout/Merger: (35%) Speculation about a potential buyout by a larger pharmaceutical company, particularly Merck, is a recurring theme, fueled by insider buying activity.
- Positive Technical Analysis/Squeeze Potential: (25%) Some posts highlight potential for a short squeeze, with bullish technical analysis and mentions of institutional buying.
- Focus on Psoriasis Pivot: (15%) Optimism surrounding the company's potential pivot to psoriasis treatment, with some seeing the recent negative data as an opportunity.
Most Critical Themes
- Concerns over Vela Phase X Study: (50%) The primary critical theme revolves around the failure of the sonelokimab drug to meet primary endpoints in the Vela phase X study for hidradenitis suppurativa.
- Negative Data and Regulatory Pathway Uncertainty: (30%) Analysts are questioning the regulatory pathway and potential approval of the drug after it failed to meet primary endpoints.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
| TikTok | XX | X% | X | X% | X | X% |
| YouTube | X | X% | X | X% | X | X% |
| Total | XXXXX | XX% | XXXXXX | XX% | XXX | X% |